Roy Jensen, MD
Director, KU Cancer Center
CEO, Masonic Cancer Alliance |
Terance T. Tsue, MD, FACS
Vice President and Physician-in-Chief, The University of Kansas Cancer Center |
Shrikant Anant, PhD
Associate Director, Basic Science
|
Joaquina Baranda, MD
Director, Early-Phase Program, Clinical Research
|
Christie Befort, PhD
Associate Director, Cancer Prevention and Control
Co-leader, Cancer Control & Population Health
|
Teresa Christenson
Associate Director
Administration |
Dan Dixon, PhD
Co-Leader,
Cancer Prevention and Survivorship
|
Gary Doolittle, MD
Medical Director,
Masonic Cancer Alliance
|
Edward Ellerbeck, MD, MPH
Co-Leader, Cancer Control and Population Health
|
Alan Gamis, MD
Co-Leader, Drug Discovery, Delivery and Experimental Therapeutics Program
|
Andrew Godwin, PhD
Deputy Director, The University of Kansas Cancer Center
Director, Biospecimen Repository
|
Jennifer Klemp, PhD
Co-leader, Cancer Prevention and Survivorship Program
|
Linheng Li, PhD
Co-leader, Cancer Biology
|
Tara Lin, MD
Medical Director, Clinical Trials Office |
Sally Maliski, PhD
Associate Director, Equity |
Matthew Mayo, PhD
Associate Director,
Shared Resources |
Kristi Neufeld, PhD
Co-Leader, Cancer Biology
|
Jeffrey Reene, MBA
Chief Operating Officer
|
Weijing Sun, MD
Division Director, Medical Oncology; Associate Director for Clinical Research
|
John Taylor, MD, MS
Co-leader, Drug Discovery, Delivery and Experimental Therapeutics |
Scott Weir, PharmD, PhD
Associate Director, Translational Research; Director, Institute for Advancing Medical Innovation
|
Danny Welch, PhD
Associate Director, Education
|